Partnerships & Alliances

Found 44,170 articles

• BC Platforms Partners with Blueprint Genetics to Provide Center of Excellence for Data Driven Testing Services in Rare Diseases

  10/17/2019

  BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a collaboration with Blueprint Genetics, a leader in the field of clinical genetic testing, to develop new data driven services for hospitals and the life sciences industry.

• Virtual Health Partners™ & HealthyResponders.com (Operated by The Holdsworth Group) Partner to Offer Virtual Health App to First Responders

  10/17/2019

  Virtual Health Partners, Inc. (VHP), a virtual health and wellness company, today announced a partnership with HealthyResponders.com, operated by The Holdsworth Group, an international consulting firm that provides marketing, strategic planning and executive coaching services to clients in the EMS, healthcare, and government industries.

• Augmented Intelligence Company PercayAI Announces Strategic Partnership with Canopy Biosciences® to Help Researchers Accelerate Drug Discovery

  10/17/2019

  PercayAI, a newly launched augmented intelligence software company that helps researchers develop new drugs more quickly and successfully, is announcing its first strategic, commercial partnership with Canopy Biosciences®.

• Synaptive Medical Expands Availability of Modus V™ into Spine Market

  10/17/2019

  Synaptive Medical, a leader in automation and robotics, announced today a strategic commercial expansion into the spinal surgery market.

• Nuance and Microsoft partner to transform the doctor-patient experience

  10/17/2019

  Strategic partnership accelerates the delivery of ambient technologies to reduce clinician burnout by enabling doctors to focus on patients, while AI focuses on administrative tasks

• Exclusive Distribution Agreement Adds eSuction Distal Cap to Olympus EndoTherapy Portfolio

  10/17/2019

  eSuction Distal Cap Aids Foreign Body Removal, Including Food Bolus Impactions

• McKesson Leads Investment in Community Pharmacy Ownership

  10/17/2019

  Ten years and 6,000 pharmacies later, RxOwnership team continues to empower pharmacy owners

• Stallergenes Greer and Anergis Initiate New Study to Predict Efficacy of Second-Generation Allergen Immunotherapy

  10/17/2019

  Second-generation Allergen Immunotherapy based on Anergis Contiguous Overlapping Peptides (COP) linked to Virosomes will be tested by Stallergenes Greer using its therapeutic model of birch pollen allergy.

• The Bristol-Myers Squibb-Pfizer Alliance and Fitbit Collaborate to Address Gaps in Atrial Fibrillation Detection with the Aim of Accelerating Diagnosis

  10/17/2019

  Leaders in atrial fibrillation and wearable technology to develop educational content around atrial fibrillation to help identify and support those at increased risk of stroke

• Teijin and NeuroSigma Enter into Exclusive License Agreement

  10/17/2019

  Teijin Pharma to Market eTNS for the Treatment of ADHD in JaAs part of the agreement, Teijin Pharma will seek regulatory approval in Japan for the Monarch eTNS System (Monarch) for the treatment of ADHD.pan

• DionyMed Receives Notice of Default and Demand for Payment and Notice of Intention to Enforce Security

  10/17/2019

  GLAS America will not have the right to enforce its security over the Company and its assets until the expiry of the 10-day period after the BIA Notice was sent unless the Company consents to an earlier enforcement.

• Rafael Pharmaceuticals Enters into Collaboration with the National Institutes of Health (NIH) to Test CPI-613® (devimistat) in Cytokine Independent (Acute) HTLV-1 Associated Adult T-cell Leukemia/Lymphoma

  10/17/2019

  Rafael will provide the compound for the study.

• Neptune Signs an Extraction Agreement in the U.S. and Expands U.S. Sales Team

  10/17/2019

  Neptune will receive hemp biomass to be processed and transformed into crude oil extracts

• FUJIFILM SonoSite, Inc. Signs Agreement With Intelligent Ultrasound Group plc To Develop Clinician Training

  10/17/2019

  The agreement includes Intelligent Ultrasound Group's BodyWorks Eve POCUS training solution and the HeartWorks transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) simulator training platforms that can be used to accelerate training for all Fujifilm SonoSite's POCUS systems.

• Centene, Walgreens and RxAdvance Announce Partnership to Provide Innovative Pharmacy Management Model

  10/17/2019

  Centene Corporation, Walgreens and RxAdvance announced a strategic partnership to introduce an innovative model for pharmacy management that aims to increase transparency, enhance customer experience and ultimately result in better health outcomes at lower costs.

• Teneobio and Selexis Expand Relationship with Three Commercial License Agreements for Multi-specific Antibody Candidates in Oncology

  10/17/2019

  Selexis SA and Teneobio, Inc. announced that they have signed three commercial license agreements for the development of Teneobio’s Human Heavy-Chain Antibodies, a new class of multi-specific biologics, for the treatment of multiple myeloma, lymphoma and prostate cancer.

• Bright Health Brings Its Innovative Model to North Carolina in Collaboration with Novant Health in 2020

  10/17/2019

  For the first time, Bright Health will offer individual and family plans to Charlotte and Winston-Salem residents in 2020.

• UM School of Pharmacy collaborates w/ tech startup emocha to offer clinical adherence solution

  10/16/2019

  The Center for Innovative Pharmacy Solutions at the University of Maryland School of Pharmacy is collaborating with emocha Mobile Health to expand the company’s clinician-led adherence solution offering.

• Orgenesis announces co-development agreement with Accellix

  10/16/2019

  Agreement Integrates Accellix’s Proprietary Quality Control Optic System, Cartridges, Reagents and Software into Orgenesis’ Point of Care Cellular Therapy Platform

• GE Healthcare and Premier Inc. to Develop Model for One-Stop Breast Cancer Diagnostic Center to Give Women in the United States Same-Day Results

  10/16/2019

  GE Healthcare and Premier Inc. (NASDAQ: PINC) have announced a collaboration to develop a model to bring a same-day breast cancer diagnosis and treatment model to the United States.